Aravind Eye Care: McDonald's-style surgery lines — paying patients fund the free ones

Govindappa Venkataswamy — Dr. V. — came from a farming family, studied medicine, and after rheumatoid arthritis crippled his hands as a young man, taught himself to hold a scalpel and became an eye surgeon. He ran Madurai's government ophthalmology department for two decades before retiring in 1976 at 58, pulling family members into his plan. His vision, a friend said, had two parts: eliminate blindness and support his family. What he carried out was an obsession with McDonald's service efficiency and a belief that its assembly line could be transplanted into surgery.

The mechanism was a two-tier price with one standard of care. Free eye camps moved through remote villages, partners covering camp and transport costs while Aravind did the operations free; at the hospitals, paying patients shared the same operating suites, the same rotating teams of doctors and nurses, as those who paid nothing. The paying half of the queue cross-subsidized the non-paying half, and because fixed costs were spread over enormous volume, the free work was not a donation — it was the system running at capacity.

When the cost of intraocular lenses threatened that arithmetic in the late 1980s, Aravind did not ration; it manufactured. Its Aurolab facility produced lenses at about $10 against a market price of $60–100, and now ships more than two million a year to 160 countries. The results: nearly 32 million patients treated and roughly 4 million surgeries by 2012, with an infection rate of 4 per 10,000 procedures versus an international norm of 6 — fewer complications in the high-volume, mixed-price model than in the richer world's low-volume one.